Ulinastatin
Ulinastatin is a pharmaceutical drug with 32 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 16 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
2
Mid Stage
9
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
94.1%
16 of 17 finished
5.9%
1 ended early
1
trials recruiting
32
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Risk Factors for Adverse Outcomes in Sepsis
Role of the Kallikrein-kinin System in Septic Cardiomyopathy
Effect of Ulinastatin on the Action of NDMRs (Rocuronium / Cisatracurium)
Ulinastatin on Systemic Immune-Inflammation in Patients With Complicated Intra-Abdominal Infection
Artificial Intelligence for Ulinastatin Responder Outcome & Risk Assessment in CPB
Clinical Trials (32)
Risk Factors for Adverse Outcomes in Sepsis
Role of the Kallikrein-kinin System in Septic Cardiomyopathy
Effect of Ulinastatin on the Action of NDMRs (Rocuronium / Cisatracurium)
Ulinastatin on Systemic Immune-Inflammation in Patients With Complicated Intra-Abdominal Infection
Artificial Intelligence for Ulinastatin Responder Outcome & Risk Assessment in CPB
Efficacy of Ulinastatin for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients
Effect of Perioperative Ulinastatin on Postoperative Stroke in Patients With Brain Tumor
AI-assisted Subtyping-directed Precision Treatment in Acute Aortic Dissection
Ulinastatin Treatment Reduces the Incidence of Sepsis-associated Encephalopathy
Ulinastatin Improves and Prevents Cardiac Dysfunction Induced by Cardiopulmonary Bypass
Protective Effect of Ulinastatin Against Negative Inflammatory Response and Organ Dysfunction After Acute Type a Aortic Dissection Surgery (PANDA I)
Ulinastatin Improves Post-Cardiac Surgery Cognitive Dysfunction
Prevention of Ulinastatin on Acute Respiratory Distress Syndrome (ARDS)
Role of Ulinastatin in Preventing Severe Sepsis and Consequent Morbidities and Mortality
Ulinastatin Treatment in Adult Patients With Sepsis and Septic Shock in China
Clinical Efficacy of Ulinastatin for Treatment of Sepsis With Systemic Inflammatory Response Syndrome
Ulinastatin for the Treatment of COVID-19 in Hospitalized Patients
Effects of Ulinastatin on Inflammatory Response During ECMO Support
The Effect of Ulistin on Acute Renal Injury in Patients Undergoing OPCAB (Off Pump Coronary Artery Bypass): a Propensity Score Matched Study
Protective Effect in Cardiac Surgery Patients
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 32